Glycosylated peptide are proteins with sugar molecules linked to them. The glycosylation process matures proteins and adds functionality to them, such as increased resistance to enzymes or bacteria in the circulation. Reduced immunogenicity, enhanced solubility, and changed receptor interactions are among the additional advantages. Furthermore, drug firms utilise them as medicines in the treatment of diseases including cancer and neurological problems.
Glycosylated peptide market growth is expected to be driven by increasing application of this peptide. Glycolastin, an anti-aging glycopeptide cosmetic active, has been trialed successfully in clinical trials by Sussex Research Laboratories Inc. They specialize in the design and production of complex carbohydrates. Studies comparing the efficacy of Glycolastin and non-glycosylated peptides found that fibroblasts secreted greater amounts of structural proteins elastin, fibronectin, and collagen. Glycolastin will also be commercialized as a cosmetic active in anti-aging topical products.
The Glycosylated peptide market growth is driven by the advantages of these peptides that have high biological activity, the availability of novel peptides on the market, and the increase in incidence of chronic diseases worldwide. Unfortunately, the intrinsic complexity of the manufacturing process and high cost of the active pharmaceutical ingredient (API) hamper the market's growth. Despite this, continued R&D efforts and increased investment by pharmaceutical companies offer ample opportunity to grow the market.
Read more @ https://cmiaspireblog.blogspot.com/2021/11/glycosylated-peptide-market-by.html
